Inactief instrument

Andere talen 2cureX AB (publ) Nasdaq Stockholm

Aandelen

SE0010468124

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

NOTICE OF ANNUAL GENERAL MEETING OF 2CUREX AB (PUBL)	29/05
Correction: Revised Financial Calendar Announcement	29/05
Revised Financial Calendar Announcement	27/05
2CUREX AB (PUBL) HAS DECIDED TO APPLY FOR A DELISTING OF ITS SHARES ON NASDAQ FIRST NORTH GROWTH MARKET IN STOCKHOLM – EXPECTED LAST DAY OF TRADING BY END OF JUNE	07/05
2CUREX AB (PUBL) PROVIDES AN UPDATE ON ITS FINANCIAL POSITION AND CURRENT OPERATIONS	16/03
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	29/02
2curex AB Elects Grith Hagel as a New Board Member	29/02
2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024	22/02
2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)	12/02
2cureX AB Announces Change to the Board of Directors	04/01
2cureX AB Announces CEO Changes	29/12
2cureX AB Announces Executive Changes, Effective 1 January 2024	29/12
2cureX Makes Executive Changes Amid Planned Global Expansion of IndiTreat Tests; Shares Drop	29/12
2cureX AB Receives Ethical Approval for HIPEC Clinical Trial	06/12
2cureX publishes interim report for the third quarter of 2023	23/11
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	14/11
2Curex AB Appoints Tonni Bülow-Nielsen as Board Member and Chairman	14/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen 2cureX AB (publ) Nasdaq Stockholm

Aandelen

SE0010468124

Andere talen

Filters